Postoperative radiation is often given in cases of cervical chordoma because of the high incidence of local recurrence. The tumor mass usually surrounds the spinal cord and infiltrates vertebral bone. A combined technique using protons or electrons to boost the initial photon fields is generally applied. We evaluated the use of dynamic intensity-modulated radiation therapy as an alternative technique for treating advanced cervical chordoma.
Methods and Study Design
A female patient with incomplete resection of a vertebral chordoma surrounding C2-C3 was irradiated with a total dose of 58 Gy (ICRU point) in 2 Gy daily fractions for 29 days between December 2001 and January 2002. Beam arrangement consisted of seven 6 MV non-opposed coplanar fields. Pretreatment quality assurance included checking of the absolute dose at reference points and 2D dose map analysis. Treatment was delivered with a 120-leaf collimator in sliding window mode. To verify the daily setup, portal images at 0° and 90° were compared with the simulation images before treatment delivery (manual matching) and after treatment delivery (automatic anatomy matching).
Results and Conclusions
The mean dose to the planning target volume (PTV) was 57.6 ± 2.1 Gy covering 95% of the PTV per 95% isodose. The minimum dose to the PTV (D99) was 53.6 Gy in the overlapping area between the PTV and the spinal cord planning organ at risk volume (PRV). The maximum dose to the spinal cord was 42.2 Gy and to the spinal cord PRV (8 mm margin) 53.7 Gy. The mean dose to the parotid glands was 37.4 Gy (homolateral gland) and 19.5 Gy (contralateral gland). Average deviation in setup was -1.1 ± 2.5 mm (anterior-posterior), 2.4 ±1.3 mm (latero-lateral), 0.7 ± 0.9 mm (craniocaudal) and -0.43 ± 1° (rotation).
Conclusions
In the treatment of chordomas surrounding the spinal cord, intensity-modulated radiotherapy can provide high dose homogeneity and PTV coverage. Frequent digital portal image-based setup control is able to reduce random positioning errors for head and neck cancer patients immobilized with conventional thermoplastic masks.
FagundesM.A., HugE.B., LiebschN.J., DalyW., EfirdJ., MunzenriderJ.E.: Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse.Int J Radiat Oncol Biol Phys,33: 579–584, 1995.
4.
SaundersW.M., CastroJ.R., ChenG.T., GutinP.H., CollierJ.M., ZinkS.R., PhillipsT.L., GaugerG.E.: Early results of ion beam radiation therapy for sacral chordoma.J Neurosurg,64: 243, 1986.
5.
BenkV., LiebschN.J., MunzenriderJ.E., EfirdJ., McManusP., SuitH.: Base of skull and cervical spine chordomas in children treated by high-dose irradiation.Int J Radiat Oncol Biol Phys,31: 577–581, 1995.
6.
BersonA.M., CastroJ.R., PettiP., PhillipsT.L., GaugerG.E., GutinP., CollierJ.M., HendersonS.D., BakenK.: Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkeley Laboratory experience.Int J Radiat Oncol Biol Phys,15: 559–565, 1988.
7.
ColliB., Al-MeftyO.: Chordomas of the craniocervical junction: follow-up review and prognostic factors.J Neurosurg,9: 933–943, 2001.
TaiP.T., CraigheadP., BagdonF.: Optimization of radiotherapy for patients with cranial chordoma. A review of dose-response ratios for photon techniques.Cancer,75: 719–756, 1995.
10.
HiginbothamN.L., PhillipsR.F., FarrH.W., HustuH.O.: Chordoma. Thirty-five-year study at Memorial Hospital.Cancer,20: 1841–1850, 1967.
11.
ForsythP.A., CascinoT.L., ShawE.G., ScheithauerB.W., O'FallonJ.R., DozierJ.C., PiepgrasD.G.: Intracranial chordomas: a clinicopathological and prognostic study of 51 cases.J Neurosurg,78: 741–747, 1993.
12.
KeischM.E., GarciaD.M., ShibuyaR.B.: Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution.J Neurosurg,75: 374–377, 1991.
13.
Proton therapy for base of skull chordoma: a report for the Royal College of Radiologists. The Proton Therapy Working Party.Clin Oncol (R Coll Radiol),12: 75–79, 2000.
De NeveW., De WagterC., De JaegerK., ThienpontM., ColleC., DeryckeS., SchelfhoutJ.: Planning and delivering high doses to targets surrounding the spinal cord at the lower neck and upper mediastinal levels: static beam-segmentation technique executed with a multileaf collimator.Radiother Oncol,40: 271–279, 1996.
16.
EsikO., BortfeldT., BendlR., NemethG., SchlegelW.: Inverse radiotherapy planning for concave-convex PTV in cervical and upper mediastinal regions. Simulation of radiotherapy using an Alderson-RANDO phantom. Planning target volume.Strahlenther Onkol,173: 193–200, 1997.
17.
PirzkallA., CarolM., LohrF., HössA., WannenmaM., DebusJ.: Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors.Int J Radiat Oncol Biol Phys,48: 1371–1380, 2000.
18.
Intensity-Modulated Radiation Therapy Collaborative Working Group: Intensity-modulated radiotherapy: current status and issues of interest.Int J Radiat Oncol Biol Phys,51: 880–914, 2001.
19.
ICRU:Prescribing, recording, and reporting photon beam therapy, Report 62 (Supplement to ICRU Report 50).International Commission on Radiation Units and Measurements, Bethesda (Maryland), 1999.
20.
BortfeldT., SchlegelW.: Optimization of beam orientations in radiation therapy: some theoretical considerations.Phys Med Biol,38: 291–304, 1993.
21.
SteinJ., MohanR., WangX.H., BortfeldT., WuQ., PreiserK., LingC.C., SchlegelW.: Number and orientation of beams in intensity-modulated radiation treatments.Med Phys,24: 149–160, 1997.
22.
AaltonenP., BrahmeA., LaxI., LevernesS., NaslundI., ReitanJ.B., TuressonI.: Specification of dose delivery in radiation therapy: recommendations by the Nordic Association of Clinical Physics (NACP).Acta Oncol, 36 (Suppl 10): 1–32, 1997.
MaciasV., BaiottoB., MunozF., GabrieleP.: Dosimetric consequences of planning target volume margins in conformal irradiation of prostate cancer.Proc ICRO/OGRO 7, Salzburg, 2002.
26.
ClausF., de GersemW., de WagterC., van SeverenR., VanhoutteI., DuthoyW., RemouchampsV., van DuyseB., VakaetL., LemmerlingM., VermeerschH., de NeveW.: An implementation strategy for IMRT of ethmoid sinus cancer with bilateral sparing of the optic pathways.Int J Radiat Oncol Biol Phys,51: 318–331, 2001.
27.
NoelG., HabrandJ.L., MammarH., PontvertD., Haie-MederC., HasbounD., MoissonP., FerrandR., BeaudreA., BoisserieG., GaboriaudG., MazalA., KeroydK., SchliengerM., MazeronJ.J.: Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de Protontherapie d'Orsay experience.Int J Radiat Oncol Biol Phys,51: 392–398, 2001.
28.
PaiH.H., ThorntonA., KatznelsonL., FinkelsteinD.M., AdamsJ.A., FullertonB.C., LoefflerJ.S., LeibschN.J., KlibanskiA., MunzenriderJ.E.: Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis.Int J Radiat Oncol Biol Phys,49: 1079–1092, 2001.
29.
EmamiB., LymanJ., BrownA., CoiaL., GoiteinM., MunzenriderJ.E., ShankB., SolinL.J., WessonM.: Tolerance of normal tissue to therapeutic irradiation.Int J Radiat Oncol Biol Phys,21: 109–122, 1991.
30.
EisbruchA., Ten HakenR.K., KimH.M., MarshL.H., ShipJ.A.: Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.Int J Radiat Oncol Biol Phys,45: 577–587, 1999.
31.
ChaoC., DesayJ.O., MarkmanJ., HaynieJ., PerezC.A., PurdyA., LowD.A.: Functional outcome of parotid gland sparing in patients with head and neck (H&N) cancers receiving intensity-modulated (IMRT) or 3-D radiation therapy.Int J Radiat Oncol Biol Phys, 48 (suppl 3): 174, 2000.
HuntM.A., KutcherG.J., BurmanC., FassD., HarrisonL., LeibelS., FucksZ.: The effect of setup uncertainties on the treatment of nasopharynx cancer.Int J Radiat Oncol Biol Phys,27: 437–447, 1993.
34.
LeibelS.A., KutcherG.J., HarrisonL.B., FassD.E., BurmanC.M., HuntM.A., MohanR., BrewsterL.J., LingC.C., FuksZ.Y.: Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx.Int J Radiat Oncol Biol Phys,20: 823–833, 1991.
VerellenD., LinthoutN., StormeG.: Target localization and treatment verification for intensity modulated conformal radiation therapy of the head and neck region. The AZ-VUB experience.Strahlenther Onkol,174: 19–27, 1998.
37.
XingL., LinZ., DonaldsonS., LeeQ.T., TateD., GoffinetD.R., WoldenS., MaL., BoyerA.L.: Dosimetric effects of patient displacement and collimator and gantry angle misalignment on intensity modulated radiation therapy.Radiother Oncol,56: 97–108, 2000.
38.
ManningM.A., WuQ., CardinaleR.M., MohanR., LauveA.D., KavanaghB.D., MorrisM.M., Schmidt-UllrichR.K.: The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer.Int J Radiat Oncol Biol Phys,51: 1400–1409, 2001.
